RxDoctor Payments Data

Kimberly Pierce, PA

Medical · Spartanburg, SCNPI 1255721395

Payments from drug & device makers

$2,195in general payments, 2019–2025

Across 104 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$346
  • United Therapeutics Corporation$243
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$211
  • Actelion Pharmaceuticals US, Inc.$190
  • Takeda Pharmaceuticals U.S.A., Inc.$188
  • Regeneron Healthcare Solutions, Inc.$177
  • plus $839 from 21 others

What the payments were for

  • Food & beverage$2,195100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,195 in reported general payments places this provider in the 65th percentile of 384 medical providers in South Carolina.

See all medical providers in South Carolina

Medicare billing

Part B allowed, 2024
$10,715
Medicare patients
89
Services billed
129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter109$102,471
NucalaMepolizumab12$44,266
Breztri AerosphereBudesonide/Glycopyr/Formoterol34$31,027
Breo ElliptaFluticasone/Vilanterol35$20,471
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr25$20,213
Incruse ElliptaUmeclidinium Bromide17$8,673
Albuterol Sulfate HfaAlbuterol Sulfate160$5,758
SymbicortBudesonide/Formoterol Fumarate13$4,320
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$2,571
Montelukast Sodium67$932
Roflumilast18$794
Wixela InhubFluticasone Propion/Salmeterol12$625
Fluticasone Propionate19$221
Doxycycline Hyclate14$103
Prednisone32$60

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Nucala, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$15$196,093198 claims
AstraZenecaBreztri Aerosphere, Symbicort$346$35,34647 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 384 medical providers in South Carolina.

Other medical in Spartanburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →